Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Bacci

Showing results (71-80 of 217) with videos related to

Pageof 22
Sort By:
Anti-Cancer Drugs|April 9, 1999
Prospective evaluation of high-dose ifosfamide-related nephrotoxicity in young adult patients with recurrent osteosarcoma previously treated with cisplatin, methotrexate and standard-dose ifosfamideS Ferrari, C Zolezzi, M Cesari, et al.
La Chirurgia Degli Organi Di Movimento|April 1, 1991
Multicentric osteosarcoma. Report of 5 casesR Biagini, P Ruggieri, R De Cristofaro, et al.
Journal of Chemotherapy (Florence, Italy)|March 17, 1999
Determination of ifosfamide by HPLC using on-line sample preparationC Zolezzi, S Ferrari, G Bacci, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|November 24, 1999
P-glycoprotein expression in osteosarcoma: a basis for risk-adapted adjuvant chemotherapyN Baldini, K Scotlandi, M Serra, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 5, 2001
Predictive factors of disease-free survival for non-metastatic osteosarcoma of the extremity: an analysis of 300 patients treated at the Rizzoli InstituteS Ferrari, F Bertoni, M Mercuri, et al.
Clinical Orthopaedics and Related Research|September 1, 1991
Telangiectatic osteogenic sarcoma of the extremities. Results in 17 patients treated with neoadjuvant chemotherapyG Pignatti, G Bacci, P Picci, et al.
La Chirurgia Degli Organi Di Movimento|April 1, 1987
[Neoadjuvant chemotherapy in malignant fibrous histiocytoma of the extremities. Preliminary results in 10 cases treated preoperatively with methotrexate and cisplatin]G Bettelli, M Avella, R Capanna, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|April 1, 1988
Adjuvant chemotherapy with six drugs (adriamycin, methotrexate, cisplatinum, bleomycin, cyclophosphamide and dactinomycin) for non-metastatic high grade osteosarcoma of the extremities. Results of 32 patients and comparison to 127 patients concomitantly treated with the same drugs in a neoadjuvant formM Avella, G Bacci, D J McDonald, et al.
Oncology Reports|June 22, 1999
Prognostic significance of serum LDH in Ewing's sarcoma of boneG Bacci, S Ferrari, A Longhi, et al.
Journal of Chemotherapy (Florence, Italy)|December 1, 1996
Methotrexate serum concentration and histological response to multiagent primary chemotherapy for osteosarcoma of the limbsG Bacci, S Ferrari, P Picci, et al.
Pageof 22

Showing results (71-80 of 217) with videos related to

Sort By:
Pageof 22
Anti-Cancer Drugs|April 9, 1999
Prospective evaluation of high-dose ifosfamide-related nephrotoxicity in young adult patients with recurrent osteosarcoma previously treated with cisplatin, methotrexate and standard-dose ifosfamideS Ferrari, C Zolezzi, M Cesari, et al.
La Chirurgia Degli Organi Di Movimento|April 1, 1991
Multicentric osteosarcoma. Report of 5 casesR Biagini, P Ruggieri, R De Cristofaro, et al.
Journal of Chemotherapy (Florence, Italy)|March 17, 1999
Determination of ifosfamide by HPLC using on-line sample preparationC Zolezzi, S Ferrari, G Bacci, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|November 24, 1999
P-glycoprotein expression in osteosarcoma: a basis for risk-adapted adjuvant chemotherapyN Baldini, K Scotlandi, M Serra, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 5, 2001
Predictive factors of disease-free survival for non-metastatic osteosarcoma of the extremity: an analysis of 300 patients treated at the Rizzoli InstituteS Ferrari, F Bertoni, M Mercuri, et al.
Clinical Orthopaedics and Related Research|September 1, 1991
Telangiectatic osteogenic sarcoma of the extremities. Results in 17 patients treated with neoadjuvant chemotherapyG Pignatti, G Bacci, P Picci, et al.
La Chirurgia Degli Organi Di Movimento|April 1, 1987
[Neoadjuvant chemotherapy in malignant fibrous histiocytoma of the extremities. Preliminary results in 10 cases treated preoperatively with methotrexate and cisplatin]G Bettelli, M Avella, R Capanna, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|April 1, 1988
Adjuvant chemotherapy with six drugs (adriamycin, methotrexate, cisplatinum, bleomycin, cyclophosphamide and dactinomycin) for non-metastatic high grade osteosarcoma of the extremities. Results of 32 patients and comparison to 127 patients concomitantly treated with the same drugs in a neoadjuvant formM Avella, G Bacci, D J McDonald, et al.
Oncology Reports|June 22, 1999
Prognostic significance of serum LDH in Ewing's sarcoma of boneG Bacci, S Ferrari, A Longhi, et al.
Journal of Chemotherapy (Florence, Italy)|December 1, 1996
Methotrexate serum concentration and histological response to multiagent primary chemotherapy for osteosarcoma of the limbsG Bacci, S Ferrari, P Picci, et al.
Pageof 22